Compare Northrop Grumman Corporation (NOC) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Northrop Grumman Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Northrop Grumman Corporation trades at $519.79 (market cap $73.24B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Northrop Grumman Corporation is far larger — about 4.1× Zimmer Biomet Holdings Inc's market cap, and Northrop Grumman Corporation pays the higher dividend (1.92%). Which is the better fit depends on your goals.
| NOC | ZBH | |
|---|---|---|
Market Cap | $73.24B | $18.05B |
Sector | Industrials | Health |
52-Week High | $768.02 | $104.26 |
52-Week Low | $496.02 | $79.58 |
Enterprise Value | $87.23B | $25.11B |
Dividend Yield | 1.92% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Northrop Grumman (NOC) trades at $518.58, up 0.7% with a bullish technical oscillator signal despite bearish moving averages. The company shows strong fundamentals with consistent earnings beats, 10.48% net margin, and record $105 billion backlog. Recent news highlights defense spending growth and successful technology tests, while institutional ownership increased significantly in Q2 2026.
Outlook remains positive with 57% analyst buy ratings and $618.43 consensus target offering 19% upside. Key risks include defense budget volatility and execution challenges on large contracts. Revenue growth acceleration to 10.48% margin by 2026 supports valuation at reasonable 16.37 P/E multiple.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Northrop Grumman Corporation
Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
